Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05749042
What this trial is testing

Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Xin-Hua Xu 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304545
What this trial is testing

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Who this might be right for
Rectal Cancer
Harbin Medical University 48
Post-approval studies (Phase 4)Study completedNCT00046969
What this trial is testing

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

Who this might be right for
AnemiaCervical Cancer
AGO Study Group 450
Testing effectiveness (Phase 2)Study completedNCT02075385
What this trial is testing

Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer

Who this might be right for
Head Neck CancerSwallowing Disorders
Barretos Cancer Hospital 94
Large-scale testing (Phase 3)UnknownNCT01000415
What this trial is testing

Comparing Study Between Concurrent Chemoradiation and New Combination Treatment in Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Thai Gynecologic Oncology Collaborative Group 824
Large-scale testing (Phase 3)Looking for participantsNCT06079671
What this trial is testing

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Who this might be right for
Locally Advanced Cervical Cancer
AstraZeneca 800
Testing effectiveness (Phase 2)UnknownNCT00620269
What this trial is testing

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

Who this might be right for
Lung CancerNSCLC
National Cancer Center, Korea 212
Early research (Phase 1)Study completedNCT02402920
What this trial is testing

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung CarcinomaNeuroendocrine Neoplasm
M.D. Anderson Cancer Center 83
Large-scale testing (Phase 3)Study completedNCT03728556
What this trial is testing

CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer Stage III
CStone Pharmaceuticals 381
Large-scale testing (Phase 3)Study completedNCT01439724
What this trial is testing

Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients

Who this might be right for
Squamous Cell Carcinoma of NasopharynxSquamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of Hypopharynx
Instituto Nacional de Cancer, Brazil 94
Testing effectiveness (Phase 2)Looking for participantsNCT05511623
What this trial is testing

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Who this might be right for
Cervical Cancer
First Affiliated Hospital of Guangxi Medical University 112
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Large-scale testing (Phase 3)Study completedNCT04210115
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Gastroesophageal Junction Carcinoma (GEJC)Esophageal Adenocarcinoma (EAC)
Merck Sharp & Dohme LLC 703
Not applicableLooking for participantsNCT05749887
What this trial is testing

The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 188
Early research (Phase 1)Study completedNCT04042935
What this trial is testing

Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC

Who this might be right for
HNSCC
University of Colorado, Denver 5
Not applicableUnknownNCT04678791
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma

Who this might be right for
Cervical Squamous Cell Carcinoma
Peking University Third Hospital 286
Testing effectiveness (Phase 2)Looking for participantsNCT06752798
What this trial is testing

Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

Who this might be right for
Head and Neck Cancer Squamous Cell Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04834206
What this trial is testing

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 32
Early research (Phase 1)WithdrawnNCT00818714
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
University of Maryland, Baltimore
Large-scale testing (Phase 3)Looking for participantsNCT07361497
What this trial is testing

Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 850
Next Page